Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-
Aim to observe the application of MR-Linac for precision radiotherapy of tumours, analyse its therapeutic effect, toxic and side effects,Characteristics of dosimetric parameters etc.
| Condition(s) | Overall Response Rate, Oncology, Radiation Toxicity, Quality of Life |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Aim to observe the application of MR-Linac for precision radiotherapy of tumours, analyse its therapeutic effect, toxic and side effects,Characteristics of dosimetric parameters etc. |
| Who can participate | Inclusion Criteria: * Patients are undergoing or have undergone imaging or treatment at the MR linac; * Age 18-75 years, male or female; * ECOG score 0-2, life expectancy \> 6 months; * Patients provide written informed consent. Exclusion Criteria: * Contraindications to MRI, such as claustrophobia and metallic or electronic implants incompatible with MRI; * The presence of severe comorbidities that, in the opinion of the investigator, ยท preclude the toleration or completion of radiotherapy; * Acute inflammatory disease requiring systemic therapy; * The presence of active infectious disease; * Pregnant women, nursing mothers, and patients planning to have children during the study period. |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Lead sponsor | The Second Affiliated Hospital of Hainan Medical University |
| Locations | Haikou, China |
| Start date | 2023-08-19 |
| NCT ID | NCT06531681 |
| Official listing | https://clinicaltrials.gov/study/NCT06531681 |